CCL2 and neoplasm: In B‐cell lymphomas, decreased H3K27 acetylation suppresses FBXW7 expression, activates the NOTCH signaling pathway and downstream CCL2/CSF1, and promotes tumor cell proliferation and M2 polarization of tumor‐associated macrophages (TAMs) [111].